Butyrylcholinesterase (BChE) is the evolutionary counterpart to acetylcholinesterase (AChE).
Introduction
Chlorpyrifos (CPF) is a widely used organophosphorus class pesticide. Because of concerns relating to neurodevelopmental toxicity, residential and public pest management use has been eliminated [1] . Epidemiological studies suggest that CPF exposure is correlated with adverse neurodevelopmental effects involving cognition, behavior and fetal growth [2] [3] [4] .
Animal studies have evaluated the developmental neurotoxicity (DNT) of CPF using endpoints including motor activity, cognition, emotion/anxiety and social interaction [5] [6] [7] [8] [9] [10] . However, the mechanism(s) responsible for these effects have not been determined, particularly in human neuronal precursor cells, the likely target in developing brain.
In animal studies, daily administration of 5 mg/kg CPF to pregnant mice between gestation days (GD) 7.5-11.5 resulted in morphological changes, including thinning of CA1 and CA3 layers of the somatosensory cortex, enlargement of the dentate gyrus of the hippocampus and a decrease in the ratio of neurons and glia in the somatosensory cortex [11] . Similar morphological changes were found in juvenile rats after prenatal CPF exposure [12] . These finding were supported by recent epidemiological data which compared high and low prenatal exposure groups and found brain changes by MRI imaging, including frontal and parietal cortical thinning [13] . Therefore, exposure to CPF during sensitive periods of development may affect the development of the nervous system.
Inhibition of acetylcholinesterase (AChE) has long been considered the primary mechanism of CPF neurotoxicity [14] . However, AChE may have a role in neurogenesis through its enzymatic activity, by interactions with other cellular factors [15] [16] [17] [18] , or through an alternate activity as an aryl acylamidase [19] . Both AChE and the pseudocholinesterase, butyrylcholinesterase (BChE), are expressed early in embryonic development [20] and display characteristic spatial and temporal regulation [21] . In neural crest cells, BChE is expressed during mitosis, followed by increased expression of AChE during migration and differentiation [22] . BChE promotes proliferation prior to differentiation [23] [24] [25] , while AChE may be involved in neurite outgrowth and cell adhesion [17] . Support for the role of AChE in neurite outgrowth is based on demonstration that blockage of the peripheral site of the enzyme changes neurite outgrowth density and may influence branching [26] . These non-classical roles for AChE and BChE have been reviewed previously [19, 26, 27] .
Neural Progenitor Cells (NPCs), also known as neural stem cells (NSCs), are multipotent and can differentiate into neurons, astrocytes and oligodendrocytes [28] . The neural ectoderm, composed of NPCs, becomes two critical layers, the ventricular zone and the marginal zone, within the fluid-filled vesicle of developing forebrain. Cell proliferation occurs through vertical cleavage, which expands the NPC population in the ventricular zone and results in cellular migration and differentiation of one daughter cell. Therefore, in vitro differentiation of NSCs provides an opportunity to assess the potential neurotoxicity of environmental factors such as exposure to CPF on aspects of early neurogenesis, including proliferation and differentiation [29, 30] . To model potential effects of CPF on early neural differentiation, we chose to use human NSC prepared from a pluripotent stem cell (iPSC) culture. Our goal was to characterize the NSC system, identify increased expression of both AChE and BChE, and then use mRNA markers of early commitment to neuronal differentiation to evaluate the effect of inhibition of cholinesterases by CPF. In addition, we examined whether BChE activity or gene expression was required during early neuronal differentiation. 
Materials and Methods

iPSC and NSC Culture
Human foreskin fibroblasts were reprogrammed into induced pluripotent stem cells (iPSC) by retroviral overexpression of transcription factors [31] and were grown feeder-free [32, 33] . iPSC were characterized and grown as described previously [33] .
NSCs were prepared as described [34] , except that Noggin was utilized to inhibit BMP pathways and promote differentiation to NSCs [35] . iPSCS were plated on BD Matrigel™ diluted in DMEM/F12 (BD Biosciences 
NSC Differentiation
For differentiation, cells were plated in T75 flasks at 13,500 cells/cm 2 and allowed to grow to confluence. On Day 0, cultures were switched to differentiation medium containing 10 ng/ml Brain Derived Neurotrophic Factor (BDNF, PeproTech) in Neurobasal plus N2
Supplement. Cells were harvested using Accutase ™ at Day 0 (prior to initiation of differentiation), Day 2, Day 4 and 6. The cell pellet was resuspended in phosphate buffered saline (PBS) and split 1/3 for RNA and 2/3 for enzyme assays. Pelleted cells were rinsed well using PBS and residual PBS was aspirated prior to freezing at -70°C.
Chlorpyrifos Exposure
Cells were exposed to CPF 10 µM (Chem Service Inc.) starting on Day 0 of differentiation. Culture medium was changed every other day during scheduled collection time points. Control cultures contained 1 µL/mL of 100% ethanol. To quantify virus the Sigma-Aldrich Lentiviral Titer p24 ELISA assay protocol was used and the viral supernatants were assayed using the Retrotek HIV-1 p24 Antigen ELISA (0801111, Zeptometrix Corp.).
Lentivirus Production and shRNA Knockdown
For knockdown experiments, cultures were seeded at a density of approximately 13,500 cells/cm 2 in 6 well plate culture dishes and then infected the next day with 6 TU per cell in medium containing 8 µg/mL protamine sulfate (Sigma Aldrich). Medium was changed the next day to remove virus and protamine sulfate, and lysates for RNA were collected on Day 0 and Day 6 of differentiation.
Quantitative Real-time Polymerase Chain Reaction
RNA was isolated using the RNeasy ® Mini Kit (Qiagen) using on-column DNase treatment. 0.8 µg RNA was reverse transcribed using SuperScript ™ (Invitrogen) using random primers. Quantitative-PCR (qPCR) was performed using Power SYBR ® Green PCR Master Mix (Applied Biosystems). Relative mRNA expression was calculated using the 2 -
Δ Δ
Ct method [36] using TBP (TATA binding protein) as a normalizing gene. Primer sequences are listed in Table   1 .
Butyrylcholinesterase and Acetylcholinesterase Enzyme Assays
A 96 well microplate assay was developed from modification of the methods described previously [5] . Frozen cell pellets were re-suspended in 200-300 µL of 50 mM Tris buffer (pH 7.4 at 37 °C). Cell pellets were sonicated using a Labsonic ® M (Sartorius Stedim Biotech).
Between 15-30 µg of protein was assayed in duplicate spectrophotometrically, using 1 mM Acetylthiocholine iodide (Sigma-Aldrich) as the substrate for AChE activity and 2 mM S-Butyrylthiocholine iodide (Sigma-Aldrich) as the substrate for BChE activity. The chromagen 5,5'-dithio-bis(nitrobezoic acid) (DTNB, Sigma-Aldrich) was used at a final assay concentration Specific activity was calculated as nmoles product formed per minute per mg protein using the extinction coefficient 14150 M -1 cm -1 .
Immunocytochemistry and Microscopy
NSCs were plated on poly-D-lysine (PDL, Sigma)/laminin (Sigma) coated 12 mm glass coverslips at 400,000 cells/well on 
Statistical Analysis
Experiments were performed at independent times and cell passages, and each independent differentiation was considered to be a biological replicate. To account for replicate differences, a one way ANOVA model was used to analyze changes in mRNA expression and enzyme activity. For CPF and lentivirus treated samples, paired t-tests were used for each time point to analyze expression differences between treatment and control. Data are presented as bar graphs with error bars representing mean ± standard error of mean (SEM).
Results
NSC Model of Early Neuronal Differentiation
NSCs were prepared from human iPSCs by switching from a proliferative medium containing FGF to a medium containing BDNF that favors differentiation ( Fig 1A) . During the initial six days of differentiation, cells transform from a homogenous appearance to one of clustered cell bodies, with outgrowth of processes visible between clusters ( Fig. 1B) . To assess NSC differentiation during this initial phase, three mRNAs were chosen as markers (Fig. 1C ).
HES5 was identified from an RNAseq analysis of similarly differentiating human ESC-derived
NSCs [37] . HES5 is a repressive transcription factor which regulates neuronal differentiation, and, along with HES1, is an effector of the Notch pathway [38] . MAP2 is a cytoskeletal protein that associated with microtubules in neurons [39] . Doublecortin (DCX) is a microtubuleassociated protein which is expressed by migrating neuroblasts during differentiation [40] To confirm the appropriate cellular identity of multipotent NSC, that they produce neurons and glia, we examined cultures differentiated for much longer periods of time for the production of mature neuronal morphologies and markers. In our previous experience with stem cell-derived NSC [41] , ~90 days normally produces robust expression of markers to evaluate neurons and astrocytes. Oligodendrocyte markers, such as MBP, were not evaluated. Cultures immunocytochemically stained after 90 days of differentiation indicated cells expressing the neuronal markers β III -tubulin (TuJ1), synaptophysin, and vesicular glutamate transporter (Vglut), each overlapping microtubule-associated protein 2 (MAP2), and the astrocytic marker GFAP, which did not overlap MAP2 ( Fig 1D) . Detection of diffuse synaptophysin immunoreactivity in the cytoplasm is consistent with neuronal expression prior to synaptogenesis, which would produce a more punctate staining. The large number of Vglut/MAP2 double-positive cells was consistent with the presence of glutamatergic neurons in these cultures. Some cells also stain positive for GFAP, which did not co-localize with MAP2, indicating astrocytes. GFAP-and MAP2-stained cells occurred in similar proportions, indicating a mixture of astrocytes and excitatory neuronal lineages. Expression of neuron and astrocyte markers at later time points indicate that NSC are multipotent and that the differentiation protocol is effective.
Butyrylcholinesterase mRNA Expression and Activity Progressively Increases
During Differentiation
To determine whether AChE and BChE are regulated during early NSC differentiation, mRNA expression and enzyme activities were detected using qPCR and spectrophotometric assays, respectively (Fig. 2) . During NSC differentiation, BChE mRNA expression and activity significantly increased during the initial 6 days. AChE mRNA and activity was unchanged relative to Day 0. This indicates that BChE mRNA expression and activity is upregulated along with other differentiation markers (HES5, DCX and MAP2), suggesting that BChE may play a role in early differentiation of NSCs.
Cholinesterase Inhibition by Chlorpyrifos Does Not Affect Neuronal Marker Expression
To test the hypothesis that CPF inhibition of cholinesterase affects early neurogenesis, NSC cultures were treated with 10 µM CPF. There was no effect on cell viability (as assayed with Alamar Blue®, not shown). CPF inhibited AChE and BChE activity 82% and 92%, respectively (Fig. 3A ). This inhibition of activity did not change expression of AChE or BChE mRNAs relative to the control group (Fig. 3B ). However, mRNA markers of neuronal differentiation (HES5, MAP2 and DCX) were not altered by CPF treatment (Fig. 3C ).
To assess the potential for metabolic activation of CPF in NSC, CYP450 and CP450 
Knockdown of BChE mRNA Alters HES5 mRNA Expression
Since CPF inhibition of BChE activity did not affect markers of early differentiation, we considered whether BChE expression is required for normal differentiation. To test this alternative hypothesis that non-enzymatic functions of BChE regulate neurogenesis, NSCs were infected with lentivirus expressing BChE or negative control shRNA 72 hours prior to induction of differentiation on Day 0 (Fig. 4A ). Knockdown of mRNA was calculated to be 72% (Fig.   4B ). BChE knockdown resulted in a significant upregulation of AChE mRNA relative to control on Day 6 ( Fig. 4C ), no change in MAP2 (Fig. 4D) or DCX (Fig. 4E ) mRNAs, but a down regulation of HES5 on Day 0 ( Fig 4F) . We conclude that BChE mRNA knockdown resulted in perturbed or delayed expression of the differentiation marker HES5.
Because HES5 is regulated by the Notch pathway, we assayed the mRNA expression of additional Notch pathway genes HES1, HES3 and the Notch ligands JAG1 and DELTA4
following BChE knockdown (Fig 4G-J) . HES1 was upregulated on Day 0 relative to the control (Fig. 4G ). The Day 0 sample was taken prior to BDNF addition and FGF withdrawal. HES3 was downregulated both on Day 0 and Day 6 ( Fig. 4H ) and the Notch ligand DELTA4 was unaffected ( Fig. 4I ) but JAG1 was down regulated on Day 6 ( Fig. 4J) . Results indicate that BChE mRNA knockdown, but not inhibition by CPF, produced changes in the mRNA expression of several developmental and Notch pathway genes, suggesting that BChE likely has a non-enzymatic role in NSC differentiation.
Discussion
We established an iPSC-derived NSC human cell culture model of early neuronal differentiation as a model for testing neurotoxicity in a human neural progenitor. This system was used to probe the DNT of CPF and to assess the function of BChE early in neurogenesis.
The NSC model consists of both a proliferative phase and a differentiation phase, with differentiation characterized by morphological changes and increased expression of the neuronal structural markers MAP2, DCX and the transcription factor HES5. These three markers were chosen from a comprehensive RNAseq analysis of NSC differentiation in an earlier study [41] as preliminary indicators for changes occurring during the initial phase of neurogenesis.
Differentiation is induced by the withdrawal of pro-mitotic FGF and the addition of differentiation-promoting BDNF. Much later in the process, after 90 days, cells stain positive for both neuronal markers, including TuJ1, synaptophysin, Vglut, and MAP2, as well as the nonoverlapping astrocytic marker GFAP ( Fig 1C) , as direct proof that the NSC cultures were multipotent. This model also displayed expression of both CPF targets BChE and AChE, although only BChE mRNA and activity was increased during the six days of differentiation.
BChE is known to be expressed at higher levels prior than AChE in early embryonic development, and, in neural crest cells, BChE is expressed during mitosis and AChE is expressed during migration and through differentiation [21] . This characteristic early expression of BChE during early differentiation is consistent with the hypothesis that BChE may have a role in early NSC differentiation.
To determine whether the catalytic activity of AChE and BChE is essential for early NSC differentiation, cells were treated continuously with a concentration of CPF sufficient to inhibit AChE and BChE activities, but not enough to cause overt cytotoxicity. Interestingly, we were able to detect expression of both the CYP3A7 and CYP450 reductase mRNAs in NSC model, likely indicating the capacity to convert CPF to its more toxic oxon.
Others have devised strategies to test neurotoxicity in cellular models of neural progenitors or neurons. In a study using NSCs derived from human umbilical cord blood to model DNT, minimal toxicity was observed at 10 µM CPF, although cells differentiated more towards an astrocytic phenotype and showed partial decrease in viability [42] . Another recent study used a commercial, immortalized human cell line to test epigenetic effects of CPF in both proliferating and differentiating NSCs, and toxic effects were not detected at concentrations below 57 µM [43] . Neither study quantified cholinesterase activity. Another study used adiposederived stem cells to model CPF toxicity [44] , but used a much higher dose of CPF (500 μM),
finding decreased viability in differentiating cells. One study examined differentiation outcomes in embryonic stem cell-derived NPCs, finding reduced proportions of glial cells upon exposure to 10-30 μM CPF [45] . Others used neuron-like cell lines including N2a and PC12 cells, identifying cellular effects such as neurite retraction [46, 47] , which would reflect events much later than the initial NSC differentiation modeled here. Our goal was to identify specific mechanisms affected early in NSC differentiation, since these events are likely to cause changes in differentiation choice, such as the reduced glial differentiation [44] , or changes in neuronal circuitry due to shifted differentiation patterns.
CPF inhibition of both AChE and BChE activities, however, did not alter expression of the early differentiation markers MAP2, DCX, or HES5 (Fig. 3C ). The dose of 10 μM CPF was chosen due to the lack of observed cytotoxicity and to mimic lower levels of exposure likely to be found in exposed subjects during fetal development. However, it is within the range of doses found to alter eventual balance of mature cell types produced later in development [45] . We conclude that CPF did not affect initial molecular mechanisms during early neurogenesis from progenitor cells.
One possibility was that neither AChE nor BChE are required for early neurogenesis.
Since we observed an increase in mRNA and activity for BChE during this phase (Fig. 2) , we considered that BChE protein may be required for differentiation of NSCs. To test this, we used lentiviral-encoded shRNA to knockdown BChE. BChE knockdown reduced expression of HES5 mRNA by over 50%, but did not affect MAP2 or DCX mRNAs, suggesting a selective effect.
Because HES5 is known to be regulated by the NOTCH signaling pathway we also determined that HES1 and JAG1 were altered (Fig. 4G,J) . Interestingly, prior to the initiation of differentiation, BChE knockdown reduced HES3 (Fig. 4H ) and HES5 (Fig. 4F ) mRNA levels, and increased HES1 (Fig. 4G) mRNA, suggesting that endogenous BChE expression affects HES signaling in NSC. The repressor-type basic helix-loop-helix (bHLH) genes HES1, HES3
and HES5 play a critical role in NSC differentiation and maintenance [48] . Activating bHLH target genes, including Mash1, Math and Neurogenin, promote neurogenesis, whereas the repressor bHLH genes promote gliogenesis, which are formed later in neural stem cell differentiation.
HES1 and HES5 are regulated by the Notch pathway [49] but HES3 is not [50] . HES1
and HES5 can compensate for each other, although HES1/HES5 double knockout mice show decreased maintenance of glial cells and increased early neurogenesis [48] . Triple knockout HES1/HES3/HES5 mice have a more severe phenotype, which results in premature differentiation of stem cells in neurons, and a loss of other cell types including astrocytes and oligodendrocytes [51] . Because HES5 expression was decreased with BChE knockdown, mediation by Notch pathway proteins is likely. The notch ligand JAG1 was decreased on Day 6 of differentiation. JAG1 is involved postnatal and adult neurogenesis in the dentate gyrus [52] , and astrocytes have been shown to decrease neurogenesis though Notch/JAG1 signaling [53] .
Based on these results, we propose that BChE may interact with other proteins in NSC and early during initial NSC differentiation through a non-enzymatic mechanism. It has been suggested that ChE may act as cell adhesion molecules (CAMs). CAMs that function in nervous system development have an extracellular domain which displays sequence homology to ChEs [54] , and the X-ray crystallography structure of human BChE had structural homology with neuroligins [55] . Knockdowns indicated that BChE antisense treatment reduced proliferation and increased differentiation and apoptosis in chick retinae [23, 25] and in a rat oligodendroglia cell line [24] . BChE antisense transfection reduced proliferation, increased protein kinase C (PKC) and pushed the cells towards an astrocytic phenotype. Finally, knockdown of BChE in R28 
Fig. 3 Inhibition of AChE and BChE by chlorpyrifos (CPF).
Cells cultures were exposed continuously to 10 µM CPF starting on Day 0 (see Fig. 1a top right). (A) AChE and BChE specific activity was assayed using a kinetic spectrophotometric assay. Both AChE and BChE were inhibited, by 82% and 92% respectively. (B) The relative mRNA expression levels of the enzymes AChE and BChE and (C) the differentiation markers MAP2, DCX and HES5 were determined by quantitative real-time PCR. There were no significant differences between the control and 10 µM CPF exposure groups. Data represent mean ± SEM (n=3). Data were analyzed using paired t-tests for each time point to account for batch variation. (*p < 0.05). (I) DELTA4 and (J) JAG1 were determined by qPCR. BChE knockdown was calculated to be 72%. AChE expression was significantly increased on Day 6 relative to control. Of the early differentiation markers, only HES5 was significantly decreased on Day 0 of differentiation, but components of the NOTCH signaling pathway (HES1, HES3, and JAG1) were affected by BChE knockdown. Data represent mean ± SEM (n=4). Data were analyzed using paired t-tests for each time point to account for batch variation. (*p < 0.05).
